CLDF Title
Contact Us | Bookmark
  HBV   HCC   HCV   HE   NASH   PBC   OTHER
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
      IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Primary liver transplant may best drainage in infants with biliary atresia
09-20-2018
REFILE-Time to revisit the PELD score for donor liver allocation, researchers say
09-19-2018
Viking shares surge after fatty liver drug trial
09-18-2018
Time to revisit the PELD score for donor liver allocation, researchers say
09-17-2018
Filtered sunlight shows promise for neonatal hyperbilirubinemia
09-17-2018
View Complete News Library
 
 
September 20-23
ALEH - Asociación Latinoamericana para el Estudio del Hígado (ALEH) / Latin American Association for the Study of the Liver
Punta Cana, Dominican Republic
October 3-7
IDSA - Infectious Diseases Society of America
San Francisco, CA, USA
October 5-10
ACG - American College of Gastroenterology
Philadelphia, PA, USA
October 20-24
UEGW - United European Gastroenterology Week
Vienna, Austria
October 20-24
NCCHC - National Commission on Correctional Health Care
Las Vegas, NV, USA
View all Congresses
 
 
 
 
 
 
 
 
 
  Line  
  Featured Abstracts          
 
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation and fibrosis
 
Safety and Efficacy of Vesatolimod (GS-9620) in Patients with Chronic Hepatitis B Who Are Not Currently on Antiviral Treatment
 
Intelligent Network DisRuption Analysis (INDRA): A targeted strategy for efficient interruption of hepatitis C transmissions
 
Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment
 
Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1
 
Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system
 
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis
 
Glecaprevir/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapy
 
 
Direct-Acting Antiviral Therapy for Hepatitis C Infection in a Large Immigrant Community
 
Assessing Disparities in the Rates of HCV Diagnoses Within American Indian or Alaska Native Populations Served by the U.S. Indian Health Service, 2005-2015
 
Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study
 
Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir + dasabuvir in patients with chronic kidney disease: an ERCHIVES study
 
Efficacy and Tolerability of Direct-Acting Antivirals for Hepatitis C in Older Adults
 
Should we cure HCV in patients with hepatocellular carcinoma while treating cancer?
 
Radioembolization Super Survivors: Extended Survival in Non-operative Hepatocellular Carcinoma
 
Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis
 
 
Non-alcoholic Steatohepatitis is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
 
Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance
 
Acute-on-Chronic Liver Failure: Getting ready for prime-time
 
Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis is Restored by Fecal Transplant
 
Management of Hepatic Encephalopathy Not Responsive to First-Line Treatments
 
Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis
 
Nonalcoholic fatty liver disease remission in men through regular exercise
 
 
          View All Abstracts  
  Line  
                               
 
HBV
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
 
HE
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
 
OTHER
Webcasts
Slide Library
   
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
             
CLDF Follow Us
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2018 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.